DMS Imaging (LTS:0RGO) Inventories, Raw Materials & Components : €12.22 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is DMS Imaging Inventories, Raw Materials & Components?

DMS Imaging's inventories, raw materials & components for the quarter that ended in Dec. 2023 was €12.22 Mil.

DMS Imaging's quarterly raw materials increased from Dec. 2022 (€10.98 Mil) to Jun. 2023 (€12.04 Mil) and increased from Jun. 2023 (€12.04 Mil) to Dec. 2023 (€12.22 Mil).

DMS Imaging's annual raw materials increased from Dec. 2021 (€9.15 Mil) to Dec. 2022 (€10.98 Mil) and increased from Dec. 2022 (€10.98 Mil) to Dec. 2023 (€12.22 Mil).

DMS Imaging Inventories, Raw Materials & Components Historical Data

The historical data trend for DMS Imaging's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DMS Imaging Inventories, Raw Materials & Components Chart

DMS Imaging Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

9.15

10.98

12.22

DMS Imaging Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Inventories, Raw Materials & Components	Get a 7-Day Free Trial															9.15	10.48	10.98	12.04	12.22

DMS Imaging Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

DMS Imaging (LTS:0RGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (LTS:0RGO) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

AS0:Germany ALIMG:Belgium

Address

7 Rue des Chasseurs Ardennais, Liege, BEL, 4031

Website

https://www.dms-imaging.com

DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

DMS Imaging (LTS:0RGO) Headlines

No Headlines